Search results for: 'deal captured sciences 2016'

Essential Benchmark Data for Dealmakers  | Global coverage | Updated to 2024 | Over a decade of royalty rates | Deal financials | Contract documents | Royalty rate trends

Artificial Intelligence (AI) Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024

Central Nervous System (CNS) Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024

The All In One Partnering Intelligence Platform

Get unlimited access to our partnering report library conveniently and easily, while maximizing your time and budget

Global Biotech Partnering Terms and Agreements 2018 to 2023 report provides a detailed understanding and analysis of how and why companies enter biotech partnering deals.

Global Pharmaceutical Partnering Terms and Agreements 2018 to 2023 report provides a detailed understanding and analysis of how and why companies enter pharmaceutical partnering deals. 

Global Specialty Pharmaceutical Partnering Terms and Agreements 2019 to 2024 report provides a detailed understanding and analysis of how and why companies enter specialty pharmaceutical partnering deals. 

Global Academic and Non-Profit Partnering Terms and Agreements 2019-2024 report provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals. 

The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024 provides comprehensive understanding and unprecedented access to clinical stage partnering agreements entered into by the world's leading biopharma companies

Provides comprehensive understanding and unprecedented access to the animal health agreements entered into by the world's leading biopharma companies.